Whilst NU-6102 showed no activity (IC50 > 10 μM), probably due to its higher sensitivity towards CDK1, AUZ 454 exhibited considerable levels of anti-tumour activity in the range of μM (Supplementary Fig. S3), suggesting an abnormal behaviour of CDK2 in HGSC. The gene discussed is CDK2; the disease is neoplasm.